A practical guide to building a CTMS business case focusing on ROI, operational efficiency, visibility, accountability, compliance, and risk reduction. Learn how clinical research organizations, academic medical centers, universities, CROs, and research institutions can quantify the cost of manual trial management and evaluate how a modern CTMS can improve study start-up, site performance, audit readiness, and research operations nationwide.

Five years ago, myLaminin began with a single idea. Today, it has evolved into a connected research ecosystem supporting the complete research lifecycle—from grant submission through publication. Discover how one conversation with a Canadian U15 university transformed our vision, how researchers co-designed our platform, and how myLaminin became a sovereign Research Data Management (RDM) and Clinical Trial Management System (CTMS) built for active science.

The new ICH E6(R3) guidelines are transforming clinical research worldwide, requiring Quality-by-Design, risk-based oversight, and validated digital systems. Discover how myLaminin's co-designed Clinical Trial Operations (CTOps) and CTMS platform helps research teams, principal investigators, administrators, and compliance professionals streamline operations, strengthen data integrity, improve audit readiness, and meet evolving global regulatory requirements with confidence.

Discover how Clinical Trial Management Systems (CTMS) help academic research institutions improve compliance, reduce administrative burden, accelerate study start-up, and support ICH E6(R3)-aligned clinical trial operations.

CROs have evolved into essential partners in clinical trials, offering scalability, expertise, and global reach amid rising complexity. However, fragmented systems, blurred oversight, and data silos create risk. The future lies in integrated platforms like myLaminin that connect sponsors, CROs, and sites, improving transparency, governance, and execution across decentralized research ecosystems.